HealthEquity (HQY) Rose as its Results Surpassed Expectations

Group 1 - ClearBridge Investments reported a strong rebound in U.S. equities during Q2 2025, with the S&P 500 Index returning 10.9% and the Russell 3000 Index advancing 11.0% due to improved risk sentiment following a pause in tariff implementation [1] - The ClearBridge Select Strategy outperformed its benchmark in Q2 2025, attributed to effective portfolio construction across various companies and sectors with unique growth drivers [1] - HealthEquity, Inc. (NASDAQ:HQY) was highlighted as a standout stock, with a one-month return of 3.64% and a 52-week gain of 19.01%, closing at $92.28 per share with a market capitalization of $7.951 billion on September 17, 2025 [2] Group 2 - HealthEquity, Inc. (NASDAQ:HQY) experienced a notable increase in share value due to better-than-expected quarterly revenue and raised full-year guidance, driven by strong growth in health savings accounts (HSAs) and assets [3] - Despite its potential, HealthEquity, Inc. (NASDAQ:HQY) was not among the 30 most popular stocks among hedge funds, with 40 hedge fund portfolios holding the stock at the end of Q2 2025, up from 32 in the previous quarter [4] - The company is recognized for its financial technology solutions for healthcare and spending decisions, indicating a growing interest in the health tech sector [2][3]